<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>HIV Quick-Reference Algorithm</title>
<meta name="viewport" content="width=device-width, initial-scale=1">
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
<style>
    :root {
        --primary: #005eb8;
        --secondary: #00a9ce;
        --danger: #d81b60;
        --success: #43a047;
        --warning: #fb8c00;
        --light: #f5f7fa;
        --dark: #212529;
        --muted: #6c757d;
    }
    *{box-sizing:border-box;margin:0;padding:0;font-family:'Inter',sans-serif;}
    body{background:var(--light);color:var(--dark);line-height:1.6;padding:20px;}
    header{text-align:center;margin-bottom:30px;}
    header h1{font-weight:700;font-size:2.2rem;color:var(--primary);}
    header p{font-size:1rem;color:var(--muted);}
    .card{background:#fff;border-radius:12px;box-shadow:0 4px 12px rgba(0,0,0,.08);padding:25px;margin-bottom:25px;}
    .card h2{display:flex;align-items:center;font-size:1.35rem;font-weight:600;margin-bottom:15px;color:var(--primary);}
    .card h2 svg{margin-right:10px;}
    .card ul{list-style:none;padding-left:0;}
    .card li{position:relative;padding-left:24px;margin-bottom:10px;font-size:0.97rem;}
    .card li::before{content:"•";position:absolute;left:0;top:0;color:var(--secondary);font-weight:bold;}
    .badge{display:inline-block;padding:3px 8px;border-radius:20px;font-size:.8rem;font-weight:600;margin-right:6px;margin-bottom:4px;}
    .badge-danger{background:var(--danger);color:#fff;}
    .badge-warning{background:var(--warning);color:#fff;}
    .badge-success{background:var(--success);color:#fff;}
    .badge-info{background:var(--secondary);color:#fff;}
    .grid{display:grid;gap:25px;grid-template-columns:repeat(auto-fit,minmax(320px,1fr));}
    footer{margin-top:40px;text-align:center;font-size:.85rem;color:var(--muted);}
    .highlight{background:#e3f2fd;border-left:4px solid var(--primary);padding:12px;margin:15px 0;border-radius:6px;font-size:.95rem;}
</style>
</head>
<body>

<header>
    <h1>HIV Quick-Reference Algorithm</h1>
    <p>Last updated: March 2025 – NICE CKS</p>
</header>

<div class="grid">

    <!-- WHEN TO TEST -->
    <div class="card">
        <h2>
            <svg width="24" height="24" fill="none" viewBox="0 0 24 24" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 5l7 7-7 7"/></svg>
            1. When to Test
        </h2>
        <ul>
            <li><strong>Symptomatic:</strong> unexplained fever, weight-loss >10 kg, lymphadenopathy, oral candida, shingles, seborrhoeic dermatitis.</li>
            <li><strong>AIDS-defining illnesses:</strong> PCP, TB, KS, lymphoma, CMV retinitis.</li>
            <li><strong>Asymptomatic:</strong> risk factors (MSM, trans women, partner HIV+, high-prevalence origin, IDU, sex work, STI, indicator conditions*).</li>
            <li><strong>Screening:</strong> annual if high-prevalence area (>2/1000) or pregnancy.</li>
        </ul>
        <div class="highlight">*Indicator conditions: any STI, lymphoma, cervical dysplasia, shingles, hepatitis B/C, unexplained cytopenias, weight-loss, oral candida, etc.</div>
    </div>

    <!-- TEST & RESULT -->
    <div class="card">
        <h2>
            <svg width="24" height="24" fill="none" viewBox="0 0 24 24" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"/></svg>
            2. Test & Result
        </h2>
        <ul>
            <li><strong>Test:</strong> 4th-generation blood test (window 4–6 wks).</li>
            <li><strong>Pre-test:</strong> consent, confidentiality, window period, risk-reduction.</li>
            <li><strong>Negative:</strong> repeat at 12 wks if recent exposure; give PrEP/PEP advice.</li>
            <li><strong>Positive:</strong> urgent (<48 h) referral to HIV clinic; provide support leaflets (THT, NAM).</li>
        </ul>
    </div>

    <!-- RED-FLAG ADMISSION -->
    <div class="card">
        <h2>
            <svg width="24" height="24" fill="none" viewBox="0 0 24 24" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"/></svg>
            3. Red-Flag Admission / Referral
        </h2>
        <ul>
            <li><span class="badge badge-danger">Admit</span> suspected PCP, TB, CMV retinitis, cryptococcal meningitis, KS lung/gut, severe ART adverse effects.</li>
            <li><span class="badge badge-warning">Refer same day</span> oesophageal candida, persistent diarrhoea, KS lesions, cervical dysplasia, neuro-cognitive decline.</li>
        </ul>
    </div>

    <!-- ESTABLISHED HIV -->
    <div class="card">
        <h2>
            <svg width="24" height="24" fill="none" viewBox="0 0 24 24" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2m-6 9l2 2 4-4"/></svg>
            4. Established HIV – Primary Care
        </h2>
        <ul>
            <li><strong>Monitoring:</strong> CD4 & viral load in specialist clinic.</li>
            <li><strong>ART adherence:</strong> missed doses → resistance; check interactions (<a href="https://www.hiv-druginteractions.org" target="_blank">hiv-druginteractions.org</a>).</li>
            <li><strong>CV prevention:</strong> offer statin ≥40 yrs (avoid simvastatin).</li>
            <li><strong>Vaccinations:</strong> inactivated OK; avoid live vaccines.</li>
            <li><strong>Cervical screening:</strong> colposcopy at diagnosis, annual cytology.</li>
            <li><strong>Mental health:</strong> screen depression/anxiety; watch drug interactions.</li>
            <li><strong>Contraception:</strong> Cu-IUD or DMPA unaffected; check ART interactions with OCP.</li>
            <li><strong>Travel:</strong> check entry restrictions, malaria prophylaxis interactions.</li>
        </ul>
    </div>

    <!-- EXPOSURE PROPHYLAXIS -->
    <div class="card">
        <h2>
            <svg width="24" height="24" fill="none" viewBox="0 0 24 24" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5.618-4.016A11.955 11.955 0 0112 2.944a11.955 11.955 0 01-8.618 3.04A12.02 12.02 0 003 9c0 5.591 3.824 10.29 9 11.622 5.176-1.332 9-6.03 9-11.622 0-1.042-.133-2.052-.382-3.016z"/></svg>
            5. Exposure Prophylaxis
        </h2>
        <ul>
            <li><strong>Occupational / Needlestick:</strong> wash wound, report → A&E for PEP within 72 h.</li>
            <li><strong>Sexual exposure (PEPSE):</strong> direct to GUM/A&E within 72 h; omit if source on ART with undetectable VL >6 m.</li>
            <li><strong>Community needlestick / bite:</strong> PEP generally not required; seek specialist advice if high risk.</li>
        </ul>
    </div>

    <!-- END-STAGE / PALLIATIVE -->
    <div class="card">
        <h2>
            <svg width="24" height="24" fill="none" viewBox="0 0 24 24" stroke="currentColor"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 8v4l3 3m6-3a9 9 0 11-18 0 9 9 0 0118 0z"/></svg>
            6. End-Stage / Palliative
        </h2>
        <ul>
            <li>Early advance-care planning; involve HIV specialist + palliative MDT.</li>
            <li>Death certificate – state HIV if related; maintain confidentiality post-mortem.</li>
        </ul>
    </div>

</div>

<footer>
    <p>Key links: <a href="https://www.bhiva.org" target="_blank">BHIVA</a> | <a href="https://www.hiv-druginteractions.org" target="_blank">Drug Interactions</a> | <a href="https://www.aidsmap.com" target="_blank">Patient Info (NAM)</a> | <a href="https://www.tht.org.uk" target="_blank">THT</a></p>
</footer>

</body>
</html>